Clobetasol propionate ketoconazole

In a 90-day repeat-dose toxicity study in rats, topical administration of clobetasol propionate foam at dose concentrations from % to % or from to mg/kg/day of clobetasol propionate resulted in a toxicity profile consistent with long-term exposure to corticosteroids including adrenal atrophy, histopathological changes in several organs systems indicative of severe immune suppression, and opportunistic fungal and bacterial infections. A no observable adverse effect level (NOAEL) could not be determined in this study. Although the clinical relevance of the findings in animals to humans is not clear, sustained glucocorticoid-related immune suppression may increase the risk of infection and possibly the risk for carcinogenesis.

Clobetasol propionate ketoconazole

clobetasol propionate ketoconazole

Media:

clobetasol propionate ketoconazoleclobetasol propionate ketoconazoleclobetasol propionate ketoconazoleclobetasol propionate ketoconazoleclobetasol propionate ketoconazole

http://buy-steroids.org